Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-06

Clinical Trial Update: Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety of Cat-PAD for treating cat allergy in individuals with controlled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cat-PAD

Snippet

Sponsor: Circassia Limited | Conditions: Cat Allergy | Phase 2 | Status: COMPLETED